Medvi, a telemedicine startup founded by Matthew Gallagher, has reached $180 million in revenue with only two full-time employees. Launched in September 2024, the company generated $401 million in sales in 2025 and is projected to hit $1.8 billion in 2026. Medvi utilizes AI for branding, marketing, and customer service, while outsourcing medical tasks to partners like CareValidate and OpenLoop. Despite its success, Medvi faces regulatory scrutiny from the FDA over the sale of compounded GLP-1 drugs. The company has expanded its offerings to include men's health products and meal delivery services. Gallagher, who has not sought external investment, attributes Medvi's achievements to his marketing expertise and AI tool utilization, though he acknowledges the challenges of operating with minimal staff.